ID: ALA1651866

Max Phase: Preclinical

Molecular Formula: C26H31Cl2N3O6

Molecular Weight: 434.37

Molecule Type: Small molecule

Associated Items:

Representations

Synonyms (1): NPC1161B
Synonyms from Alternative Forms(1):

    Canonical SMILES:  COc1cc(N[C@H](C)CCCN)c2nccc(C)c2c1Oc1ccc(Cl)c(Cl)c1.O=C(O)CCC(=O)O

    Standard InChI:  InChI=1S/C22H25Cl2N3O2.C4H6O4/c1-13-8-10-26-21-18(27-14(2)5-4-9-25)12-19(28-3)22(20(13)21)29-15-6-7-16(23)17(24)11-15;5-3(6)1-2-4(7)8/h6-8,10-12,14,27H,4-5,9,25H2,1-3H3;1-2H2,(H,5,6)(H,7,8)/t14-;/m1./s1

    Standard InChI Key:  VWFHXOIAXIAYQN-PFEQFJNWSA-N

    Associated Targets(non-human)

    Canis familiaris 36305 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Plasmodium berghei 192651 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Leishmania donovani 89745 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Pneumocystis carinii 749 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Plasmodium falciparum 966862 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Plasmodium yoelii 6656 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Molecule Features

    Natural Product: NoOral: NoChemical Probe: NoParenteral: No
    Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
    Chirality: NoAvailability: NoProdrug: No

    Drug Indications

    MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

    Mechanisms of Action

    Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

    Properties

    Molecular Weight: 434.37Molecular Weight (Monoisotopic): 433.1324AlogP: 6.19#Rotatable Bonds: 8
    Polar Surface Area: 69.40Molecular Species: BASEHBA: 5HBD: 2
    #RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
    CX Acidic pKa: CX Basic pKa: 10.20CX LogP: 4.86CX LogD: 2.26
    Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.44Np Likeness Score: -0.39

    References

    1. Nanayakkara NP, Ager AL, Bartlett MS, Yardley V, Croft SL, Khan IA, McChesney JD, Walker LA..  (2008)  Antiparasitic activities and toxicities of individual enantiomers of the 8-aminoquinoline 8-[(4-amino-1-methylbutyl)amino]-6-methoxy-4-methyl-5-[3,4-dichlorophenoxy]quinoline succinate.,  52  (6): [PMID:18378716] [10.1128/aac.00645-07]
    2. Dechy-Cabaret O, Benoit-Vical F..  (2012)  Effects of antimalarial molecules on the gametocyte stage of Plasmodium falciparum: the debate.,  55  (23): [PMID:23075290] [10.1021/jm3005898]
    3. Flannery EL, Fidock DA, Winzeler EA..  (2013)  Using genetic methods to define the targets of compounds with antimalarial activity.,  56  (20): [PMID:23927658] [10.1021/jm400325j]

    Source